Portail Guide

12. What role do dermocosmetics play in wound healing?

Some dermocosmetic products may be beneficial during the early phase of healing and should be used in the days after the formation of the acute wound. Such products are often enriched with copper and zinc (antibacterial action) but can also include various healing molecules.


Patients often use cosmetic products whose purpose is to hide and improve the aesthetic appearance of scars. They are also well tolerated and can significantly improve the aesthetic appearance thus enhancing the quality of life of patients. Some products offer enhanced covering properties compared to conventional products, have a thick texture and are available as compact or fluid foundation products. Patient associations, such as burns associations, offer training in the best way of concealing scars using these products.




References


1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341: 738-46.

2. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol2007; 127: 514-25.

3. Suivi en ville des plaies chroniques : ulcère veineux de jambe, escarre, plaie du pied diabétique. Assurance maladie, octobre 2015.

4. Plaies aiguës en structure d’urgence. Référentiel de bonnes pratiques. SFMU, 2017: 32 p.

5. Sgonc R, Gruber J. Age-related aspects of cutaneous wound hea- ling: a mini-review. Gerontology 2013; 59: 159-64.

6. Majtan J. Honey: an immunomodulator in wound healing. Wound Repair Regen 2014; 22: 187-92.

7. Opletalová K, BlaizotX, Mourgeon B, et al. Maggot therapyfor wound debridement: a randomized multicenter trial. Arch Dermatol 2012; 148: 432-8.

8. van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S. Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissueengineering perspective. ExpDer- matol 2014; 23: 382-6.

9. Prise en charge de l’ulcère de jambe à prédominance veineuse hors pansement. Recommandations HAS, 2006.

10. La compression médicale dans les affections veineuses chroniques. Fiche de bon usage HAS, 2010.

11. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, et al. Sucrose octasulfate dressing versus control dressing in patients with neu- roischaemic diabetic foot ulcers (Explorer): an international, multi- centre, double-blind, randomised, controlled trial [published correction appears in Lancet Diabetes Endocrinol 2018]. Lancet Diabetes Endocrinol 2018; 6: 186-96.

12. Reinholz M, Poetschke J, Schwaiger H, Epple A, Ruzicka T, Gauglitz GG. The dermatology life quality index as a means to assess life quality in patients with different scar types. J Eur Acad Dermatol Venereol 2015; 29: 2112-9.



<< 11. What dressing should be used according to the appearance of the wound? >> 13. Is there a role for alternative therapies in wound healing?
© John Libbey Eurotext, 2021 This work may not be reproduced in whole or in part without the permission of the publisher or the Centre Francois d’Exploitation du Droit de Copie (CFC), 20, rue des Grands-Augustins, 75006 Paris, France.

With the institutional support of the laboratories